Viyash Scientific quarterly results and financials

Viyash Scientific (VIYASH)₹237.51+1.21%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), Viyash Scientific reported sales of ₹948 Cr, up 19.3% from Jun 2025, and net profit of ₹78.96 Cr, up 113.3% year on year. For the year to Mar 2026, sales were ₹3,432 Cr and net profit ₹225 Cr.

Sales (Jun 2026): ₹948 Cr
Net profit (Jun 2026): ₹78.96 Cr
Sales (FY Mar 2026): ₹3,432 Cr
Net profit (FY Mar 2026): ₹225 Cr
EPS (Jun 2026): ₹1.52
Borrowings (Mar 2026): ₹492 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Viyash Scientific quarterly results

₹ crore unless stated; each column is a quarter.

Viyash Scientific Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	347	330	362	391	370	776	403	795	852	861	923	948
Expenses	330	306	328	348	329	673	354	672	675	682	734	767
Operating Profit	15.06	22.09	32.14	42.15	39.16	100	46.19	119	174	177	185	179
OPM %	4.4%	7.0%	9.0%	11.0%	11.0%	13.0%	11.9%	15.0%	20.0%	20.0%	20.0%	19.0%
Other Income	10.03	7.02	−1.01	3.01	0.00	4.01	1.01	6.02	6.01	−27.08	16.04	8.02
Interest	13.02	13.02	12.02	16.04	14.03	21.04	15.03	20.03	18.03	17.03	15.02	13.02
Depreciation	15.01	15.01	16.02	16.02	17.03	58.10	16.01	56.09	59.06	59.04	60.08	62.09
Profit before tax	−2.99	0.99	2.99	11.99	7.99	23.98	15.99	47.94	102	72.88	125	112
Tax %	123.1%	−616.9%	52.1%	24.1%	20.1%	−70.9%	36.1%	24.1%	29.1%	34.0%	47.1%	29.1%
Exceptional items	−9.96	−1.99	−0.99	0.00	0.00	0.00	0.00	−0.99	−0.99	−11.96	0.00	0.00
Net Profit	−7.01	10.99	0.99	9.01	5.99	42.01	9.99	37.02	72.95	48.95	65.96	78.96
EPS (Rs)	−0.35	0.34	−0.05	0.27	0.11	1.79	0.38	1.28	2.19	0.89	1.20	1.52

Viyash Scientific profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Viyash Scientific Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	608	686	850	1,041	1,182	1,366	1,418	1,424	1,373	3,016	3,432	3,584
Expenses	549	640	763	912	1,007	1,149	1,300	1,407	1,306	2,616	2,762	2,858
Operating Profit	56.18	43.19	83.25	125	171	213	109	12.05	61.26	389	655	714
OPM %	9.0%	6.0%	10.0%	11.9%	14.0%	16.0%	8.0%	0.8%	4.5%	12.9%	19.0%	19.9%
Other Income	14.04	9.03	437	9.03	10.03	0.00	11.03	−58.18	−6.02	−49.11	−1.01	2.99
Interest	38.10	28.08	33.06	33.08	36.08	24.05	16.03	36.09	48.09	86.16	69.09	63.10
Depreciation	46.04	40.04	41.05	42.01	51.02	51.06	52.05	56.09	62.09	239	234	240
Profit before tax	−13.99	−16.98	444	58.99	93.87	137	52.96	−138	−54.97	12.99	349	412
Tax %	19.1%	−3.0%	3.0%	3.0%	13.1%	24.1%	15.1%	−11.0%	−45.9%	−20.0%	36.1%	—
Exceptional items	0.99	−0.99	−0.99	0.00	0.00	−3.99	0.00	−58.84	−8.98	6.98	−24.91	−12.95
Net Profit	−16.01	−15.99	431	56.94	81.94	104	44.96	−122	−29.98	15.99	225	267
EPS (Rs)	−0.79	−0.58	17.32	1.98	2.82	3.85	1.66	−4.87	−1.45	0.94	4.07	5.80
Dividend payout %	0.0%	0.0%	1.0%	10.1%	0.0%	13.1%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Viyash Scientific balance sheet

₹ crore, at each year end.

Viyash Scientific Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	30.09	48.05	49.04	49.06	49.13	50.12	50.14	50.12	50.18	50.17	50.19	87.27
Reserves	61.21	900	930	600	659	639	680	644	652	609	2,392	2,834
Borrowings	474	312	416	305	326	344	278	366	446	490	657	492
Other Liabilities	345	266	505	382	348	426	383	380	376	391	1,047	1,201
Total Liabilities	911	1,526	1,901	1,335	1,383	1,459	1,391	1,439	1,523	1,540	4,146	4,614
Fixed Assets	476	588	687	478	500	579	538	566	607	595	2,112	2,110
CWIP	39.14	24.07	33.08	18.05	23.08	13.04	31.08	12.04	55.12	16.04	43.11	70.17
Investments	58.95	427	428	239	180	171	82.83	37.95	0.00	3.99	0.00	0.00
Other Assets	337	486	753	601	680	696	740	824	860	926	1,990	2,432
Inventories	94.35	136	162	160	201	220	265	349	347	348	685	806
Trade receivables	115	192	254	257	278	319	346	328	340	335	805	1,043
Cash & equivalents	37.99	25.01	47.04	42.01	72.01	76.02	56.04	59.06	42.04	70.08	157	270
Total Assets	911	1,526	1,901	1,335	1,383	1,459	1,391	1,439	1,523	1,540	4,146	4,614

Viyash Scientific cash flow

₹ crore, for each year.

Viyash Scientific Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−24.01	0.00	−6.99	45.05	116	115	115	31.01	17.02	30.99	345	323
Cash from investing activity	−158	−311	−116	7.03	−68.18	−72.26	10.03	−94.35	−65.23	−6.02	−450	−84.33
Cash from financing activity	180	310	148	−57.22	−20.08	−43.15	−140	67.28	32.13	−1.01	87.29	−124
Net cash flow	−1.01	−2.01	24.02	−5.01	28.02	0.00	−14.01	4.01	−16.02	23.04	−16.03	115
Capex	118	65.95	78.87	46.97	24.98	40.96	52.90	31.95	85.92	30.97	108	135
Free cash flow	−137	−63.20	−82.24	0.00	92.29	75.30	70.30	−1.01	−58.17	19.08	259	226
CFO / OP %	−142.9%	−3.0%	5.0%	65.1%	92.1%	75.1%	75.1%	52.1%	263.0%	73.1%	102.1%	59.1%

Viyash Scientific ratios

Working-capital days and returns, by year.

Viyash Scientific Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	94	115	135	110	97	98	92	84	87	88	97	111
Inventory days	153	164	165	125	134	132	139	160	152	166	169	188
Days payable	147	175	208	127	141	133	119	119	107	121	121	140
Cash conversion cycle	100	104	92	109	91	97	111	125	131	134	145	159
Working capital days	−111	65	−25	20	33	29	51	54	46	30	74	111
ROCE %	8.0%	2.0%	1.0%	40.0%	9.0%	12.0%	16.0%	6.0%	−3.0%	0.0%	8.0%	13.0%

Viyash Scientific: frequently asked questions

What are the latest quarterly results of Viyash Scientific?

For the Jun 2026 quarter, Viyash Scientific reported sales of ₹948 Cr, up 19.3% year on year and net profit of ₹78.96 Cr, up 113.3% year on year. The operating margin was 19.0%.

What is the annual revenue of Viyash Scientific?

Viyash Scientific's sales for the year to Mar 2026 were ₹3,432 Cr; over the last twelve months they were ₹3,584 Cr.

What is the net profit of Viyash Scientific?

Net profit for the year to Mar 2026 was ₹225 Cr, and ₹267 Cr over the last twelve months. Earnings per share over the same trailing period were ₹5.80.

How much debt does Viyash Scientific have?

Viyash Scientific reported borrowings of ₹492 Cr at Mar 2026, against cash and equivalents of ₹270 Cr.

What is the free cash flow of Viyash Scientific?

Cash from operations was ₹323 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹226 Cr.

Loading…